These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33401010)

  • 1. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway.
    Wang D; Ning Z; Zhu Z; Zhang C; Wang P; Meng Z
    Int J Biochem Cell Biol; 2021 Mar; 132():105845. PubMed ID: 33401010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines.
    Ma L; Sun H; Xu X; Chen Y; Zhang L; Li S; Tang L
    J Physiol Biochem; 2022 Nov; 78(4):807-817. PubMed ID: 35796893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
    Meng K; Li Z; Cui X
    J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway.
    Hou B; Li W; Xia P; Zhao F; Liu Z; Zeng Q; Wang S; Chang D
    Cell Death Discov; 2021 Oct; 7(1):273. PubMed ID: 34608127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.
    Sun X; Zhang K; Peng X; Zhou P; Qu C; Yang L; Shen L
    Cancer Lett; 2023 May; 562():216158. PubMed ID: 37023940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
    Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liao L; Duan D; Liu Y; Chen L
    Cell Cycle; 2020 Jul; 19(14):1846-1854. PubMed ID: 32578511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling.
    Li C; Yang J; Wang W; Li R
    J Bioenerg Biomembr; 2021 Feb; 53(1):61-71. PubMed ID: 33394310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Li Y; Zhang X; Zhou X; Zhang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
    Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
    PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histidine phosphatase LHPP: an emerging player in cancer.
    Wu F; Ma H; Wang X; Wei H; Zhang W; Zhang Y
    Cell Cycle; 2022 Jun; 21(11):1140-1152. PubMed ID: 35239447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.
    Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM
    J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis.
    Yang X; Meng L; Zhong Y; Hu F; Wang L; Wang M
    Aging (Albany NY); 2021 Jan; 13(2):2864-2884. PubMed ID: 33418541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.
    Zhu H; Song C; Li J; Liu Q; Liu M; Fu L
    Med Oncol; 2023 Jul; 40(9):257. PubMed ID: 37522936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.